The classification helps answer the question: "What am I actually taking, and how does it compare to what I read about online?" [Diagram suggestion: Four-quadrant matrix with axes labeled "Receptor target" (pure GLP-1 vs multi-agonist) and "Approval status" (FDA-approved vs compounded), with all medications plotted in their respective quadrants] The pattern we see in FormBlends refill data: patients often start on compounded semaglutide (Tier 4), then switch to brand-name Wegovy (Tier 1) when insurance coverage becomes available, then switch to tirzepatide (Tier 3) if weight loss plateaus
Semaglutide Semaglutide, originally developed for managing blood sugar levels in people with diabetes, is now an FDA-approved weight loss solution
Amylin analogs are challenging to manufacture because amylin is notoriously aggregation-prone, requiring specific amino-acid substitutions and synthesis controls
The Science Behind Semaglutide Semaglutide mimics GLP-1 (glucagon-like peptide-1), a naturally occurring hormone that regulates appetite and metabolism
You cannot visually confirm contamination, and the risk of introducing bacteria into your reconstituted peptide is not worth the cost of a replacement vial